Followers | 270 |
Posts | 15407 |
Boards Moderated | 1 |
Alias Born | 03/28/2013 |
Thursday, September 01, 2016 12:43:21 AM
Roughly 1/3 is a large fraction imo
Not trying to yell fire just don't understand the excitement per my understanding
Not much has changed here
Perhaps I'm wrong
hope so...
What I am excited about is the fact that Alzheimers has gained traction in the collective conscious
May this lead to positive outcomes the world over...
Hoping for the best, as always
Much love and respect
Recent BIIB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:14:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 09:57:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 09:56:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/09/2024 03:33:58 PM
- "LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico • PR Newswire (US) • 12/04/2024 11:31:00 PM
- "LEQEMBI®" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea • PR Newswire (US) • 11/28/2024 12:31:00 AM
- Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity • GlobeNewswire Inc. • 11/19/2024 06:00:14 AM
- Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease • PR Newswire (US) • 11/14/2024 06:29:00 PM
- Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease • GlobeNewswire Inc. • 11/14/2024 04:23:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 09:23:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:39:18 PM
- Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 10/30/2024 11:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:45:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 08:31:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 10:55:17 AM
- US Futures Rise as Tech Earnings Drive Market Optimism; Oil Prices Edge Up • IH Market News • 10/30/2024 10:37:30 AM
- Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases • GlobeNewswire Inc. • 10/29/2024 10:00:23 PM
- Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 • GlobeNewswire Inc. • 10/28/2024 12:30:00 PM
- Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 • GlobeNewswire Inc. • 10/27/2024 12:15:00 AM
- Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference • GlobeNewswire Inc. • 10/24/2024 11:30:00 AM
- Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 • GlobeNewswire Inc. • 10/22/2024 11:30:00 AM
- Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients • GlobeNewswire Inc. • 10/09/2024 11:30:00 AM
- New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group • UMAV • Jan 6, 2025 9:26 AM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM